Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The citric acid cycle (also known as the Krebs cycle or tricarboxylic acid [TCA] cycle) is a central metabolic pathway that takes place in the mitochondrial matrix of eukaryotic cells. It is responsible for the oxidative catabolism of carbohydrates, fats, and proteins, converting acetyl-CoA into carbon dioxide while generating high-energy electron carriers (NADH and FADH2) and GTP/ATP. The enzymes catalyzing this cycle are essential for cellular respiration and energy production. The main enzymes involved are: Citrate synthase, Aconitase, Isocitrate dehydrogenase, α-Ketoglutarate dehydrogenase complex, Succinyl-CoA synthetase, Succinate dehydrogenase, Fumarase, and Malate dehydrogenase. Defects in these enzymes can lead to metabolic disorders affecting energy production. Some intermediates/enzyme activities are also targets for certain drugs or toxins.
Enzyme Inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Citric Acid Cycle Enzymes (TCA Enzymes).